参考文献/References:
[1] MCEVOY J P,LIEBERMAN J A,STROUP T S,et al.Effectiveness of clozapine versus olanzapine,quetiapine,and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment[J].Am J Psychiatry,2006,163(4): 600-610.
[2] STROUP T S,LIEBERMAN J A,MCEVOY J P,et al.Effectiveness of olanzapine,quetiapine,risperidone,and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic[J].Am J Psychiatry,2006,163(4): 611-622.
[3] LEUCHT S,CIPRIANI A,SPINELI L,et al.Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis[J].Lancet,2013,382(9896): 951-962.
[4] TSCHONER A,ENGl J,LAIMER M,et al.Metabolic side effects of antipsychotic medication[J].Int J Clin Pract,2010,61(8): 1356-1370.
[5] 徐丹怡,沈建国.性别与胰岛素抵抗[J].国际内分泌代谢杂志,2007,27(1): 13-15.
[6] TANG Q,LI X,SONG P,et al.Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: developments in research and prospects for the future[J].Drug Discov Ther,2016,9(6): 380.
[7] LI H,PENG S,LI S,et al.Chronic olanzapine administration causes metabolic syndrome through inflammatory cytokines in rodent models of insulin resistance[J].Sci Rep,2019,9(1):1582.
[8] 常麦会.氯、奥氮氮平平对大鼠骨骼肌GLUT4基因表达的影响[D].长沙: 中南大学,2011.
[9] ALBAUGH V L,HENRY C R,BELLO N T,et al.Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents[J].Obesity,2012,14(1): 36-51.
[10] 王翟.高脂饲料喂养大鼠诱导的脂代谢紊乱对糖代谢及炎症因子的影响[J].卫生研究,2008,37(2): 190-193.
[11] 孙保恩,邢渊.炎症因子与代谢综合征[J].实用糖尿病杂志,2015,11(3): 61-63.
[12] 陈思娇,都镇先,张海燕,等.2型糖尿病患者血清抵抗素水平与血糖和炎症因子的关系[J].中华内分泌代谢杂志,2006,22(2): 151-153.
[13] 邹大进,李慧.肥胖、炎症与胰岛素抵抗[J].国际内分泌代谢杂志,2004,24(4): 2-5.
[14] 李焱.炎症与胰岛素抵抗[J].中国实用内科杂志,2005,13(11): 81-82.
[15] 张魁.早期生长反应因子1促进炎症加重静脉桥血管再狭窄相关机制的实验研究[C].第八届北京五洲国际心血管病会议论文集,2014:629-630.
[16] SHEN N,YU X,PAN F Y,et al.An early response transcription factor,Egr-1,enhances insulin resistance in type 2 diabetes with chronic hyperinsulinism[J].J Biol Chem,2011,286(16): 14508-14515.
[17] PAZ K,HEMI R,LEROITH D,et al.A molecular basis for insulin resistance.Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation[J].J Biol Chem,1997,272(47):29911-29918.
[18] YU X,SHEN N,ZHANG M L,et al.Egr-1 decreases adipocyte insulin sensitivity by tilting PI3K/Akt and MAPK signal balance in mice[J].EMBO J,2014,30(18): 3754-3765.
相似文献/References:
[1]李怀祥,校庆志,王保琴,等.胰岛素抵抗与高血压病冠心病糖尿病[J].新乡医学院学报,1996,13(02):116.
[2]宋晓敏 杨 冰 杜 玮 郭长磊 李根旺 邬玉芳 郭丽萍.豆番粉与玉米粉对人体血糖胰岛素胰升血糖素的影响[J].新乡医学院学报,1998,15(03):234.
[3]秦海梅,杜玮,徐青.Graves病患者糖代谢紊乱60例临床观察[J].新乡医学院学报,2001,18(02):132.
[4]型糖尿病合并高血压的胰岛素敏感性探讨.2型糖尿病合并高血压的胰岛素敏感性探讨[J].新乡医学院学报,2003,20(02):124.
[5]秦海梅,杜 玮,徐 青.2 型糖尿病合并高血压的胰岛素敏感性探讨[J].新乡医学院学报,2003,20(02):124.
[6]乔汉臣.非酒精性脂肪肝病研究进展[J].新乡医学院学报,2006,23(06):630.
[7]张 强,朱榕峰,刘 爽,等.高脂诱导非酒精性脂肪性肝病小鼠肝脏Chemerin及其受体的表达[J].新乡医学院学报,2009,26(03):224.
ZHANG Qiang,ZHU Rong-feng,LIU Shuang,et al.Expression of Chemerin and it′s receptor in liver of mouse with nonalcoholic fatty liver disease induced by high fat diet[J].Journal of Xinxiang Medical University,2009,26(12):224.
[8]田莉娜.2型糖尿病伴非酒精性脂肪肝相关因素分析[J].新乡医学院学报,2010,27(04):394.
[9]王素平,陈 娟.老年原发性高血压患者胰岛素抵抗与颈动脉粥样硬化的关系 [J].新乡医学院学报,2012,29(10):798.
[10]马伏英1,樊毫军2,周小双1,等.有氧运动对高脂膳食金黄地鼠糖脂代谢及肝脏过氧化物酶增殖体受体的影响[J].新乡医学院学报,2014,31(05):343.[doi:10.7683/xxyxyxb.2014.05.006]